Colloid Infusion for Optimal Outcomes In Non-cardiac Surgery (COIN Trial) (COIN)
Postoperative Complications
About this trial
This is an interventional prevention trial for Postoperative Complications
Eligibility Criteria
Inclusion Criteria: 18 years or older ASA I-III Undergoing elective non-cardiac surgery under general aneathesia Exclusion Criteria: Allergic to colloids Severe heart diseases ( Ejection Fraction lower than 35%) Presence of renal failure pre-operatively (defined as eGFR < 30 mL/min/1.73 m2 and/or patient receiving renal replacement therapy) Morbid obesity (BMI > 37.5kg/m2 or > 32.5kg/m2 with metabolic diseases) Presence of a coagulopathy at screening (defined as platelet count < 100 × 109/L and/or a prothrombin time < 70% and/or an activated partial thromboplastin time (aPTT) >35 s and/or fibrinogen <1 g/ L) Presence of liver injury (defined as Child-Pugh C) Pre-operative electrolyte disturbances with Na >160 mmol/L or <120 mmol/L Patients with preoperative intracranial hypertension requiring dehydration treatment
Sites / Locations
- Xijing HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
colloid group
crystalloid group
The participants in colloid group will received intravenous Hydroxyethyl Starch 130/0.4 and Electrolyte injection of 5ml/kg before the Induction of general anesthesia.
The participants in crystalloid group will received intravenous multiple electrolyte injection of 5ml/kg before the Induction of general anesthesia.